Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-25-040241
Filing Date
2025-04-28
Accepted
2025-04-28 16:31:16
Documents
22
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2512660-4_def14a.htm   iXBRL DEF 14A 473402
6 GRAPHIC tm2512660d4_def14aimg001.jpg GRAPHIC 223352
7 GRAPHIC tm2512660d4_def14aimg002.jpg GRAPHIC 149835
8 GRAPHIC tm2512660d4_def14aimg003.jpg GRAPHIC 220025
9 GRAPHIC tm2512660d4_def14aimg004.jpg GRAPHIC 148985
10 GRAPHIC tm2512660d4_def14aimg005.jpg GRAPHIC 2160
  Complete submission text file 0001104659-25-040241.txt   3096912

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clrb-20241231.xsd EX-101.SCH 10042
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clrb-20241231_def.xml EX-101.DEF 3042
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20241231_lab.xml EX-101.LAB 35400
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20241231_pre.xml EX-101.PRE 6820
25 EXTRACTED XBRL INSTANCE DOCUMENT tm2512660-4_def14a_htm.xml XML 153324
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36598 | Film No.: 25880872
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)